TherapeuticsMD Inc (NASDAQ:TXMD)

1.85
Delayed Data
As of Feb 25
 -0.05 / -2.63%
Today’s Change
1.82
Today|||52-Week Range
6.09
-23.55%
Year-to-Date
TherapeuticsMD Inc (TXMD) Q4 2019 Earnings Call Transcript
Feb 20 / MotleyFool.com - Paid Partner Content
Is TherapeuticsMD Stock a Buy?
Feb 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close1.90
Today’s open1.93
Day’s range1.83 - 1.97
Volume4,867,854
Average volume (3 months)3,888,342
Market cap$558.6M
Data as of 3:59pm ET, 02/25/2020

Growth & Valuation

Earnings growth (last year)-21.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+208.38%
P/E ratioNM
Price/Sales12.01
Price/Book60.71

Competitors

 Today’s
change
Today’s
% change
ACIUAC Immune SA-0.58-7.37%
MISTMilestone Pharmaceut...-0.58-2.83%
NLTXNeoleukin Therapeuti...+0.65+6.44%
CRNXCrinetics Pharmaceut...-0.97-4.29%
Data as of 4:00pm ET, 02/25/2020

Financials

Last reporting dateFebruary 20, 2020
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$49.6M
Annual profit (last year)-$176.1M
Net profit margin-354.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
No executives to display
Corporate headquarters
Boca Raton, Florida

Forecasts